Document is current
Any future updates will be listed below
-
Authors
Myrstad, Christian
Larssen, Marie
Engdahl, Bo
Selbæk, Geir
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 24 November 2025
First Online: 16 December 2025
Declarations
:
: The HUNT data collection was approved by the Norwegian Data Protection Authority. Participation was based on an informed written consent. When a participant’s ability to consent was reduced, based on the judgment of health personnel in nursing homes and assessors, informed written consent was provided by the closest proxy. The HUNT participants have consented to linkage to the many high-quality health and administrative registries in Norway, including Statistics Norway (Statistisk sentralbyrå) used in this project. The study received ethical approval from the Regional Committees for Medical and Health Research Ethics (‘23178 HUNT hørsel’) in accordance with the Norwegian Act on Medical and Health Research (“Helseforskningsloven”).
: Not applicable.
: GS has participated in advisory boards for Biogen, Eisai and Roche concerning antidementia drugs. All the other authors declare that they have no competing interests.
